178 related articles for article (PubMed ID: 4205544)
1. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
[No Abstract] [Full Text] [Related]
2. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
3. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
4. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Losert W; Hoder A; Scholz C
Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
[No Abstract] [Full Text] [Related]
5. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
6. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
Lorch E; Gey KF; Sommer P
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
[No Abstract] [Full Text] [Related]
7. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
8. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
9. Glipizide: experimental study and comparison with other sulfonylureas.
Loubatieres-Mariani MM
Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
[No Abstract] [Full Text] [Related]
10. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
Rizzi G; Isaia GC
Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
[No Abstract] [Full Text] [Related]
11. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
Bickel M; Geisen K; Schleyerbach R
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
[TBL] [Abstract][Full Text] [Related]
12. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
[No Abstract] [Full Text] [Related]
13. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
14. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
Beyer J; Cordes U; Sell G; Krall H; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
[No Abstract] [Full Text] [Related]
15. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
[No Abstract] [Full Text] [Related]
16. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
Alemany M; Palou A; Codina J; Herrera E
Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
[No Abstract] [Full Text] [Related]
17. The effect of oral sulphonylureas on blood glucose and insulin.
Adadevoh BK; Bolodeoku JO
Ghana Med J; 1973 Dec; 12(4):360-5. PubMed ID: 4282692
[No Abstract] [Full Text] [Related]
18. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
19. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
Balant L
Diabete Metab; 1978 Jun; 4(2):135-43. PubMed ID: 98364
[No Abstract] [Full Text] [Related]
20. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
